| 2022 |
| Fiscal Impact Statement: HB102F122.PDF 2022-01-21 |
| Fiscal Impact Statement: HB102FH1122.PDF 2022-02-12 |
| Name | Karen S. Greenhalgh |
|---|---|
| Name | G. "John" Avoli |
| Name | Ronnie R. Campbell |
| Name | Marie E. March |
| Name | Phillip A. Scott |
| Name | Wren M. Williams |
| Name | Greenhalgh |
| Name | R Karen S. Greenhalgh |
| Name | R Marie E. March |
| Name | R Phillip A. Scott |
| Name | R Wren M. Williams |
| Name | Dave A. LaRock |
| Name | R Tara A. Durant |
Prescriptions; off-label use. Provides that a prescriber may prescribe, administer, or dispense and a pharmacist may dispense a drug that has been approved for a specific use by the U.S. Food and Drug Administration for an off-label use when the prescriber or pharmacist determines, in his professional judgment, that such off-label use is appropriate for the standard of care and such prescribing, administering, or dispensing is to improve health care outcomes. The bill also prohibits a hospital from denying, revoking, terminating, diminishing, or curtailing in any way any professional or clinical privilege of any licensed health care provider with prescriptive authority or authority to dispense drugs solely on the grounds that such health care provider prescribes, administers, or dispenses a drug that has been approved for a specific use by the U.S. Food and Drug Administration for an off-label use, provided that such prescribing, administering, or dispensing is in accordance with laws of the Commonwealth and is to improve health care outcomes.
Passed by indefinitely in Education and Health (8-Y 7-N)
Referred to Committee on Education and Health
Constitutional reading dispensed
VOTE: Passage (52-Y 46-N)
Passed Read third time and passed House (52-Y 46-N)
Engrossed by House - committee substitute HB102H1
Committee substitute agreed to 22104743D-H1
Read second time
Read first time
Impact statement from DPB (HB102H1)
Committee substitute printed 22104743D-H1
House committee, floor amendments and substitutes offered
Reported from Health, Welfare and Institutions with substitute (12-Y 10-N)
Subcommittee recommends reporting with substitute (5-Y 4-N)
House subcommittee amendments and substitutes offered
Assigned HWI sub: Subcommittee #1
Impact statement from DPB (HB102)
Referred to Committee on Health, Welfare and Institutions
Prefiled and ordered printed; offered 01/12/22 22103672D